Log in to save to my catalogue

Repurposing ketoconazole as an exosome directed adjunct to sunitinib in treating renal cell carcinom...

Repurposing ketoconazole as an exosome directed adjunct to sunitinib in treating renal cell carcinom...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_8bcce53528064b139c18bf1570a9c148

Repurposing ketoconazole as an exosome directed adjunct to sunitinib in treating renal cell carcinoma

About this item

Full title

Repurposing ketoconazole as an exosome directed adjunct to sunitinib in treating renal cell carcinoma

Publisher

London: Nature Publishing Group UK

Journal title

Scientific reports, 2021-05, Vol.11 (1), p.10200-10200, Article 10200

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Renal Cell Carcinoma (RCC) is the most common form of kidney cancer, with clear cell RCC (ccRCC) representing about 85% of all RCC tumors. There are limited curable treatments available for metastatic ccRCC because this disease is unresponsive to conventional targeted systemic pharmacotherapy. Exosomes (Exo) are small extracellular vesicles (EVs) s...

Alternative Titles

Full title

Repurposing ketoconazole as an exosome directed adjunct to sunitinib in treating renal cell carcinoma

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_8bcce53528064b139c18bf1570a9c148

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_8bcce53528064b139c18bf1570a9c148

Other Identifiers

ISSN

2045-2322

E-ISSN

2045-2322

DOI

10.1038/s41598-021-89655-w

How to access this item